On November 17th, specialists from the Netherlands, the United Kingdom, and Michigan discussed their methods for achieving very high levels of active monitoring during a webinar hosted by the Active Surveillance Coalition.   Although active surveillance has been shown to prevent prostate cancer overtreatment, most nations still neglect it. According to American models, cost-effective prostate...

African American patients are more comfortable working with providers of the same race. Still, only about 3% of US oncologists are Black, reducing participation during medical visits. Providers believed African American care could be improved by increasing cultural sensitivity through education and training initiatives and increasing staff diversity. A recent study indicated a need to...

Comorbidity can be summed up in a simple question: “In addition to cancer, what else is wrong with you?” A comorbidity is an existing and unrelated diagnosis at the time of a cancer diagnosis. Common comorbidities include heart disease, diabetes, hypertension, and obesity. Nearly 30 such comorbid conditions occur frequently enough and contribute to treatment...

Shared decision-making and value-based care are emerging approaches to obtaining additional value from patient care. Shared decision-making is the process of interacting with patients who wish to be involved in arriving at an informed, values-based choice among two or more medically reasonable alternatives. It attempts to stimulate collaborative discussion between physicians and patients to better...

While a cancer diagnosis can strike fear into the hearts of many, there are now effective treatments for many types of the disease. There is a sizable population of people who have survived cancer, particularly in Western nations like the United States and Europe. Scientific progress in cancer treatment, such as advances in technology, detection/diagnostic...

GET IN TOUCH
MyCancerJourney is a combination of patient advocacy and personalized treatment decision support. We are changing how patients engage in cancer treatment decisions; it is a compassionate, personalized, whole person approach.
Follow us on socials
Find out what we're up to:

Copyright PotentiaMetrics, Inc. All rights reserved.